7th February 2021

🔛 Feels good.. it’s risk-on

No straight line, but up and away… The tea leaves are once again aligned – and the message is clear: risk prices are in the ascendancy. J&J’s one-shot vaccine is weeks away from emergency approval. The $1.9trn covid relief package has been approved by the US congress, and in its entirety after their Vice President’s […]
Subscribers can log in to continue reading. Otherwise, purchase The Monthly Access Pass or One Year Subscription to become a subscriber.

Suki Mann

A 30+ year veteran of the European corporate bond markets and in his role as Credit Strategist, Dr Mann has been ranked number one in the Euromoney Investor Survey eight times in ten years. Previously with Societe Generale and UBS, he now shares views of events in the corporate bond market exclusively here on CreditMarketDaily.com.